Meral Esen
Meral Esen
Institut für Tropenmedizin, Tübingen
Verified email at - Homepage
Cited by
Cited by
Sterile protection against human malaria by chemoattenuated PfSPZ vaccine
B Mordmüller, G Surat, H Lagler, S Chakravarty, AS Ishizuka, ...
Nature 542 (7642), 445-449, 2017
Respiratory syncytial virus and other respiratory viral infections in older adults with moderate to severe influenza-like illness
AR Falsey, JE McElhaney, J Beran, GA Van Essen, X Duval, M Esen, ...
The Journal of infectious diseases 209 (12), 1873-1881, 2014
Atypical and classical memory B cells produce Plasmodium falciparum neutralizing antibodies
MF Muellenbeck, B Ueberheide, B Amulic, A Epp, D Fenyo, CE Busse, ...
Journal of Experimental Medicine 210 (2), 389-399, 2013
The IκB Kinase Complex and NF-κB Actas Master Regulators of Lipopolysaccharide-Induced Gene Expressionand Control Subordinate Activation ofAP-1
D Krappmann, E Wegener, Y Sunami, M Esen, A Thiel, B Mordmuller, ...
Molecular and cellular biology 24 (14), 6488-6500, 2004
Lymphotoxin and lipopolysaccharide induce NF‐κB‐p52 generation by a co‐translational mechanism
B Mordmüller, D Krappmann, M Esen, E Wegener, C Scheidereit
EMBO reports 4 (1), 82-87, 2003
Mechanisms of Staphylococcus aureus induced apoptosis of human endothelial cells
M Esen, B Schreiner, V Jendrossek, F Lang, K Fassbender, H Grassme, ...
Apoptosis 6, 431-439, 2001
AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial
JE McElhaney, J Beran, JM Devaster, M Esen, O Launay, G Leroux-Roels, ...
The Lancet infectious diseases 13 (6), 485-496, 2013
Safety and immunogenicity of GMZ2—a MSP3–GLURP fusion protein malaria vaccine candidate
M Esen, PG Kremsner, R Schleucher, M Gässler, EB Imoukhuede, ...
Vaccine 27 (49), 6862-6868, 2009
Natural infection of Plasmodium brasilianum in humans: man and monkey share quartan malaria parasites in the Venezuelan Amazon
A Lalremruata, M Magris, S Vivas-Martínez, M Koehler, M Esen, ...
EBioMedicine 2 (9), 1186-1192, 2015
Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres
B Mordmüller, C Supan, KL Sim, GP Gómez-Pérez, CL Ospina Salazar, ...
Malaria journal 14, 1-11, 2015
Immune responses to a recombinant glycoprotein E herpes zoster vaccine in adults aged 50 years or older
AL Cunningham, TC Heineman, H Lal, O Godeaux, R Chlibek, SJ Hwang, ...
The Journal of infectious diseases 217 (11), 1750-1760, 2018
First-in-human, randomized, double-blind clinical trial of differentially adjuvanted PAMVAC, a vaccine candidate to prevent pregnancy-associated malaria
B Mordmüller, M Sulyok, D Egger-Adam, M Resende, WA de Jongh, ...
Clinical Infectious Diseases 69 (9), 1509-1516, 2019
Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized …
D Kieninger, E Sheldon, WY Lin, CJ Yu, JM Bayas, JJ Gabor, M Esen, ...
BMC infectious diseases 13, 1-13, 2013
A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children
SB Sirima, B Mordmüller, P Milligan, UA Ngoa, F Kironde, F Atuguba, ...
Vaccine 34 (38), 4536-4542, 2016
Plasmodium falciparum-infected erythrocytes induce granzyme B by NK cells through expression of host-Hsp70
E Böttger, G Multhoff, JFJ Kun, M Esen
PLoS One 7 (3), e33774, 2012
Invasion of Human Epithelial Cells byPseudomonas aeruginosa Involves Src-Like Tyrosine Kinases p60Src and p59Fyn
M Esen, H Grassmé, J Riethmüller, A Riehle, K Fassbender, E Gulbins
Infection and immunity 69 (1), 281-287, 2001
Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial
N Wressnigg, EM Pöllabauer, G Aichinger, D Portsmouth, A Löw-Baselli, ...
The Lancet infectious diseases 13 (8), 680-689, 2013
Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambarene, Gabon
B Mordmüller, K Szywon, B Greutelaers, M Esen, L Mewono, C Treut, ...
Vaccine 28 (41), 6698-6703, 2010
A randomized controlled phase Ib trial of the malaria vaccine candidate GMZ2 in African children
S Belard, S Issifou, AB Hounkpatin, F Schaumburg, UA Ngoa, M Esen, ...
PloS one 6 (7), e22525, 2011
A randomized controlled phase Ib trial of the malaria vaccine candidate GMZ2 in African children
S Belard, S Issifou, AB Hounkpatin, F Schaumburg, UA Ngoa, M Esen, ...
PloS one 6 (7), e22525, 2011
The system can't perform the operation now. Try again later.
Articles 1–20